Boston Scientific Corp (BSX)
Boston Scientific Market Cap: 109.75B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 109.75B |
May 16, 2024 | 109.60B |
May 15, 2024 | 109.45B |
May 14, 2024 | 108.04B |
May 13, 2024 | 107.04B |
May 10, 2024 | 108.34B |
May 09, 2024 | 108.94B |
May 08, 2024 | 106.91B |
May 07, 2024 | 107.96B |
May 06, 2024 | 106.66B |
May 03, 2024 | 107.10B |
May 02, 2024 | 105.90B |
May 01, 2024 | 106.16B |
April 30, 2024 | 105.66B |
April 29, 2024 | 106.59B |
April 26, 2024 | 107.56B |
April 25, 2024 | 107.69B |
April 24, 2024 | 107.18B |
April 23, 2024 | 101.42B |
April 22, 2024 | 99.99B |
April 19, 2024 | 98.98B |
April 18, 2024 | 99.11B |
April 17, 2024 | 99.90B |
April 16, 2024 | 100.14B |
April 15, 2024 | 99.14B |
Date | Value |
---|---|
April 12, 2024 | 100.06B |
April 11, 2024 | 101.20B |
April 10, 2024 | 100.92B |
April 09, 2024 | 100.93B |
April 08, 2024 | 100.97B |
April 05, 2024 | 100.78B |
April 04, 2024 | 99.59B |
April 03, 2024 | 100.15B |
April 02, 2024 | 99.15B |
April 01, 2024 | 100.11B |
March 28, 2024 | 100.67B |
March 27, 2024 | 100.86B |
March 26, 2024 | 99.86B |
March 25, 2024 | 98.91B |
March 22, 2024 | 99.39B |
March 21, 2024 | 99.31B |
March 20, 2024 | 99.13B |
March 19, 2024 | 99.64B |
March 18, 2024 | 98.84B |
March 15, 2024 | 97.35B |
March 14, 2024 | 98.28B |
March 13, 2024 | 97.07B |
March 12, 2024 | 99.20B |
March 11, 2024 | 97.19B |
March 08, 2024 | 99.45B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
ResMed Inc | 32.11B |
Stryker Corp | 127.50B |
Align Technology Inc | 20.44B |
Abbott Laboratories | 181.08B |
Axonics Inc | 3.446B |
Market Cap Related Metrics
PE Ratio | 62.73 |
PS Ratio | 7.474 |
PEG Ratio | 0.6169 |
Price to Book Value | 5.508 |
Price to Free Cash Flow | 70.78 |
Price | 74.65 |
Earnings Yield | 1.59% |
PEGY Ratio | 0.6169 |
Operating PE Ratio | 43.53 |
Normalized PE Ratio | 58.17 |